Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Genes Cells
2013 Jun 01;186:442-9. doi: 10.1111/gtc.12048.
Show Gene links
Show Anatomy links
WNK4 is an essential effector of anterior formation in FGF signaling.
Shimizu M
,
Goto T
,
Sato A
,
Shibuya H
.
???displayArticle.abstract???
With no lysine (K) (WNK) kinase family is conserved among many species and regulates SPAK/OSR1 and ion cotransporters. WNK is also involved in developmental and cellular processes, but the molecular mechanisms underlying its regulation in these processes remain unknown. In this study, we found that WNK4 is involved in fibroblast growth factor (FGF) signaling during Xenopus development. In Xenopus embryos, depletion of WNK4 by antisense morpholino oligonucleotides (MOs) results in a severe defect in anterior development and impaired expression of endogenous anterior markers. Defects in head formation or expression of anterior marker genes caused by suppression of endogenous WNK4 expression could be rescued by expression of wild-type WNK4, but not mutant WNK4 lacking its kinase activity. It is notable that morphants of Xenopus WNK4 inhibited the expression of anterior marker genes and the target genes induced by FGF signaling. Moreover, knockdown of Wnk4 significantly reduced the phosphorylation level of Osr1 induced by FGF. These results provide the first evidence that FGF signaling regulates WNK4 function required for anterior formation in Xenopus development.
Figure 1. Alignment of the Xenopus WNK4 (xWNK4) and human WNK4 (hWNK4). The conserved amino acids are represented by asterisks (*). The kinase domains have high identity (88%) and are shaded gray.
Figure 4. Xenopus WNK4 is involved in fibroblast growth factor (FGF) signaling. (A) RT-PCR analysis of neural marker genes, NCAM and BF-1, and FGF-target genes, FoxD5a, Spry2 and Zic3. Control-MO (10 ng) or xWNK4-MO (10 ng) was co-injected with FGFR1(CA) mRNA (250 pg) into four animal blastomeres of 8-cell embryos, and animal cap explants were dissected at stage 9 and cultured until stage 18. RNAs from animal cap explants were extracted at stage 18. WE: whole embryos. (B) Western blotting analysis. Control-MO (30 ng) or xWNK4-MO (30 ng) was co-injected with FGFR1(CA) mRNA(250 pg) and/or mOSR1 mRNA (50 pg) into four animal blastomeres of 8-cell embryos. Animal caps were dissected at the early gastrula stage (st.10) and were lysed.
Figure 2. Temporal and spatial expression of xWNK4. (A) RT-PCR was carried out using 1 μg of total RNA extracted from Xenopus embryos at different stages. 'U' indicates the unfertilized eggs, and numbers indicate the developmental stages. xWNK4 is maternally expressed, and its zygotic expression increased after neurula stage (st.14). (B-E) Localization of xWNK4 transcripts by whole-mount in situ hybridization. At the gastrula stage, xWNK4 is entirely expressed in ectodermal region (B, vegetal view, stage 10.5). Expression of xWNK4 is gradually restricted to anterior neural region (lateral view, C; stage 17, D; stage 23, E; stage 27).
Figure 3. xWNK4 functions in anterior neural development. (A) Morpholino (MO) (20 ng) and FLAG-tagged mRNAs (1000 pg) were co-injected with β-globin-FLAG mRNA (200 pg) as loading control into the animal poles of 4-cell stage embryos, and the injected animal caps were dissected at stage 10. Lysates from the animal caps were subjected to Western blotting with anti-FLAG antibody (M2, Sigma). (B-E) Phenotypes of injected embryos at stage 35. Control-MO (30 ng) or xWNK4-MO (30 ng) was co-injected with xWNK4 mRNA (1000 pg) or kinase negative xWNK4 mRNA (1000 pg) into two dorso-animal blastomeres of 8-cell embryos. (B) Control-MO. (C) xWNK4-MO. (D) xWNK4-MO with xWNK4 mRNA. (E) xWNK4-MO with kinase negative xWNK4 mRNA. (F) RT-PCR analysis of neural marker genes, NCAM (pan-neural), BF-1 (forebrain) and Rx1 (eye). RNAs from head regions of injected embryos were extracted at stage 25.
Bhargava,
The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action.
2001, Pubmed,
Xenbase
Bhargava,
The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action.
2001,
Pubmed
,
Xenbase
Bier,
Anti-neural-inhibition: a conserved mechanism for neural induction.
1997,
Pubmed
,
Xenbase
Castañeda-Bueno,
Independent regulation of Na+ and K+ balance by the kidney.
2012,
Pubmed
Dailey,
Mechanisms underlying differential responses to FGF signaling.
2005,
Pubmed
Eswarakumar,
Cellular signaling by fibroblast growth factor receptors.
2005,
Pubmed
Fukumoto,
Actions and mode of actions of FGF19 subfamily members.
2008,
Pubmed
Gagnon,
Volume sensitivity of cation-Cl- cotransporters is modulated by the interaction of two kinases: Ste20-related proline-alanine-rich kinase and WNK4.
2006,
Pubmed
,
Xenbase
Gordon,
Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate.
1986,
Pubmed
Hardcastle,
FGF-8 stimulates neuronal differentiation through FGFR-4a and interferes with mesoderm induction in Xenopus embryos.
2000,
Pubmed
,
Xenbase
Harland,
Neural induction.
2000,
Pubmed
,
Xenbase
Harland,
In situ hybridization: an improved whole-mount method for Xenopus embryos.
1991,
Pubmed
,
Xenbase
Hisamoto,
Caenorhabditis elegans WNK-STE20 pathway regulates tube formation by modulating ClC channel activity.
2008,
Pubmed
Hongo,
FGF signaling and the anterior neural induction in Xenopus.
1999,
Pubmed
,
Xenbase
Kengaku,
bFGF as a possible morphogen for the anteroposterior axis of the central nervous system in Xenopus.
1995,
Pubmed
,
Xenbase
Lamb,
Fibroblast growth factor is a direct neural inducer, which combined with noggin generates anterior-posterior neural pattern.
1995,
Pubmed
,
Xenbase
Launay,
A truncated FGF receptor blocks neural induction by endogenous Xenopus inducers.
1996,
Pubmed
,
Xenbase
Moniz,
Emerging roles for WNK kinases in cancer.
2010,
Pubmed
Moriguchi,
WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.
2005,
Pubmed
Na,
Disease-causing R1185C mutation of WNK4 disrupts a regulatory mechanism involving calmodulin binding and SGK1 phosphorylation sites.
2013,
Pubmed
,
Xenbase
Pera,
Neural and head induction by insulin-like growth factor signals.
2001,
Pubmed
,
Xenbase
Piechotta,
Cation chloride cotransporters interact with the stress-related kinases Ste20-related proline-alanine-rich kinase (SPAK) and oxidative stress response 1 (OSR1).
2002,
Pubmed
Powers,
Fibroblast growth factors, their receptors and signaling.
2000,
Pubmed
Richard-Parpaillon,
The IGF pathway regulates head formation by inhibiting Wnt signaling in Xenopus.
2002,
Pubmed
,
Xenbase
Ring,
An SGK1 site in WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone signaling and K+ homeostasis.
2007,
Pubmed
,
Xenbase
San-Cristobal,
Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway.
2009,
Pubmed
,
Xenbase
Sasai,
Ectodermal patterning in vertebrate embryos.
1997,
Pubmed
,
Xenbase
Sasai,
Endoderm induction by the organizer-secreted factors chordin and noggin in Xenopus animal caps.
1996,
Pubmed
,
Xenbase
Sato,
WNK signaling is involved in neural development via Lhx8/Awh expression.
2013,
Pubmed
Sun,
Down-regulation of WNK1 protein kinase in neural progenitor cells suppresses cell proliferation and migration.
2006,
Pubmed
Talati,
Effect of angiotensin II on the WNK-OSR1/SPAK-NCC phosphorylation cascade in cultured mpkDCT cells and in vivo mouse kidney.
2010,
Pubmed
Tu,
WNK1 is required for mitosis and abscission.
2011,
Pubmed
Veríssimo,
WNK kinases, a novel protein kinase subfamily in multi-cellular organisms.
2001,
Pubmed
Vitari,
The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.
2005,
Pubmed
Weinstein,
Neural induction.
1999,
Pubmed
,
Xenbase
Wilson,
An early requirement for FGF signalling in the acquisition of neural cell fate in the chick embryo.
2000,
Pubmed
,
Xenbase
Wilson,
Human hypertension caused by mutations in WNK kinases.
2001,
Pubmed
Wilson,
Vertebrate neural induction: inducers, inhibitors, and a new synthesis.
1997,
Pubmed
,
Xenbase
Xie,
Endothelial-specific expression of WNK1 kinase is essential for angiogenesis and heart development in mice.
2009,
Pubmed
,
Xenbase
Xu,
WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II.
2000,
Pubmed
Yang,
Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model.
2007,
Pubmed
Zagórska,
Regulation of activity and localization of the WNK1 protein kinase by hyperosmotic stress.
2007,
Pubmed
Zambrowicz,
Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention.
2003,
Pubmed
van der Lubbe,
Angiotensin II induces phosphorylation of the thiazide-sensitive sodium chloride cotransporter independent of aldosterone.
2011,
Pubmed
